1. Home
  2. |Insights
  3. |Say Goodbye To CCR and Hello To SAM

Say Goodbye To CCR and Hello To SAM

Client Alert | less than 1 min read | 05.21.12

According to a post on Central Contractor Registration's website, "On May 29, 2012, the Central Contractor Registration (CCR) system is going away. CCR, along with Federal Agency Registration (FedReg), the Online Representations and Certifications Application (ORCA), and the Excluded Parties List System (EPLS), will be migrated into the new System for Award Management, or SAM." While some details about this transition to SAM are currently available, the government is planning on providing additional information and training materials soon, and contractors should follow these developments closely because the government is reporting that CCR will stop accepting data at 11:59 pm on Wednesday, May 23, 2012, and no new registrations or updates can be submitted via CCR after that time.


Contacts

Insights

Client Alert | 7 min read | 09.14.26

AI in Life Sciences: Ten Legal Considerations and Risks of AI Use in Drug Discovery and Development

Over the past several years, the biopharmaceutical industry has embraced artificial intelligence and machine learning (AI/ML) in near lockstep with the pace of AI/ML innovations. Today, industry leaders are using AI/ML to, among other things: discover and assess biological pathways, target chemical structures and sequences; design proteins; model pre-clinical and clinical trials; recruit and screen potential patient populations; evaluate clinical trial results and biomarker data; prepare regulatory filings; and manage supply chains. Deployment of new AI/ML models promises extraordinary advances in pharmaceutical development. However, as with any technological and scientific advances, the use of AI/ML also poses substantial legal risks that life sciences companies need to consider and proactively manage. ...

View All Insights